{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Indiana",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "96764",
      "recalling_firm": "RemedyRePack Inc.",
      "address_1": "625 Kolter Dr Ste 4",
      "address_2": "N/A",
      "postal_code": "15701-3571",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Within U.S - PA, VA, FL.",
      "recall_number": "D-0411-2025",
      "product_description": "Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02",
      "product_quantity": "23 bottles/30 count- 690 capsules",
      "reason_for_recall": "CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.",
      "recall_initiation_date": "20250422",
      "center_classification_date": "20250506",
      "report_date": "20250514",
      "code_info": "Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.",
      "more_code_info": ""
    }
  ]
}